Entering text into the input field will update the search result below

Recro Pharma reports FY results

  • Recro Pharma (REPH): FY EPS of -$2.82
  • Revenue of $69.33M (+33.5% Y/Y)
  • Press Release

Recommended For You

More Trending News

About SCTL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SCTL--
Societal CDMO, Inc.